Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase IIA trial of oral AOD-9604 scheduled to begin next month

April 16, 2002

New MC4-selective agonists useful in obesity, etc.

April 15, 2002

Calcium receptor antagonists especially useful in osteoporosis according to JT

April 15, 2002

Hypolipidemic agents acting via inhibition of apo B secretion described by Tanabe

April 11, 2002

Estradot launched in Germany for menopausal symptoms

April 11, 2002

Oratonin enters clinical testing for osteoporosis

April 11, 2002

Axokine phase III program expanded with two new studies

April 11, 2002

Inhibitors of DPP-IV and potential uses thereof described in recent patent

April 10, 2002

ACS news: nonsteroidal GR-selective antagonists discovered by Abbott and Karo Bio

April 10, 2002

Nonsteroidal LXR agonist with good potency and selectivity discovered at GSK

April 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...